-IBIS-1.7.6-
tx
cardiovascular system
atherosclerosis
Botanicals

primary herbs

Allium cepa: aids blood cholesterol levels (NCNM Botanicals)
Allium sativum: (NCNM Botanicals)
Commiphora mukul (Guggul)
Crataegus oxyacantha: aids circulation, arteriosclerosis
(Weiss, p. 162; British Herbal Pharmacopoeia, p. 75)
Dioscorea spp.: (Anderson Geller)
Drosera rotundifolia (Weiss, p. 210)
Ginkgo biloba (standardized extract): for intermittent claudication, impaired mental performance (NCNM Botanicals)
Olea europaea (NCNM Botanicals)
Scutellaria spp.: decreases elevated serum cholesterol (Anderson Geller)
Selenicereus grandiflorus (toxic): cardiac weakness with atheroma or arteriosclerosis, with Crataegus spp. (Priest and Priest, p. 91)
Strophanthus hispidus (Ellingwood, p. 221)
Taraxacum officinale: aids liver function (NCNM Botanicals)
Tilia platyphyllos: arteriosclerotic hypertension; with Crataegus oxyacantha (British Herbal Pharmacopoeia, p. 214)
Viscum album (toxic): arteriosclerosis, heart conditions, high blood pressure
(British Herbal Pharmacopoeia, p. 236; Ellingwood, p. 153)


complementary herbs

arteriosclerosis:
Crataegus oxyacantha (fruit) combines well with Tilia platyphyllos, Viscum album (toxic), or Scutellaria lateriflora (British Herbal Pharmacopoeia, p. 75)

formula: tincture:
Allium ursinum, 4 parts
Crataegus oxyacantha, 4 parts
Arnica montana (toxic), half part
Viscum album (toxic), 4 parts.
instructions: 10 drops, three times daily, over a long period (Sherman)


footnotes

[No author listed.] Garlic powder for hyperlipidemia-analysis of recent negative results. Quart Rev Natural Med 1998;Fall:187-189.

Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism. JAMA 1998;279:1900-1902.

Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc) and fenugreek (Trigonella foenumgraceum L) on blood lipids, blood sugar, and platelet aggregation in patients with coronary artery disease. Prostagland Leukotrienes Essential Fatty Acids 1997;56:379-384.

Braquet P, Touqui L, Shen TS, Vargaftig BB. Perspectives in platelet activating factor research. Pharmacol Rev 1987;39:97-210.

British Herbal Medicine Association. British Herbal Pharmacopeia. West Yorks, England: BHMA, 1983.

Ellingwood F. American Materia Medica, Therapeutics and Pharmacognosy, 11th ed. Sandy, OR: Eclectic Medical Publications, 1919, 1998.

Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-1011.

Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-386.

Hertog MGL, Sweetnam PM, Fehily AM, et al. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997;65:1489-1494.

Isaacsohn JL, Moser M, Stein EA, et al. Garlic powder and plasma lipids and lipoproteins. Arch Intern Med 1998;158:1189-1194.

Janssen PLTMK, Meyboom S, van Staveren WA, de Vegt F, Katan MB. Consumption of ginger (Zingiber officinale Roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996;50:772-774.

Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneim Forsch Drug Res 1990;40:589-593.

Kiesewetter H et al. Effect of garlic on thrombocyte aggregation, microcirculation and other risk factors. Int J Pharm Ther Toxicol 1991;29(4):151-154.

Kiesewetter H, Jung F, Mrowietz C, et al. Effects of garlic on blood fluidity and fibrinolytic activity: A randomised, placebo-controlled, double-blind study. Br J Clin Pract Suppl 1990;69:24-29.

Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996;312:478-481.

Lawson L. Garlic oil for hypercholesterolemia-negative results. Quart Rev Natural Med 1998;Fall:185-186.

Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemost 1994;7:110-111.

Mavers VWH, Hensel H. Changes in local myocardial blood flow following oral administration to a Crataegus extract to non-anesthetized dogs. Arzneim Forsch 1974;24:783-785.

McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 1998;152:1089-1094.

Neil HAW, Silagy CA, Lancaster T, et al. Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and a meta-analysis. J R Coll Phys 1996;30:329-334.

Phelps S, Harris WS. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 1993;28(5):475-477.

Pulliero G, Montin S, et al. Ex vivo study of the inhibitory effects of Vaccinium myrtillus (bilberry) anthocyanosides on human platelet aggregation. Fitoterapia 1989;60:69-75.

Sharma RD, Raghuram TC, Dayasagar Rao V. Hypolipidaemic effect of fenugreek seeds. A clinical study. Phytother Res 1991;5:145-147.

Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic, prevents oxidation of low density lipoprotein. Phytother Res 1997;11:291-294.

Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prost Leuk Essen Fat Acids. 1995;52:223-227.

Srivastava KC, Tyagi OD. Effect of a garlic derived principle (ajoene) on aggregation and arachidonic acid metabolism in human blood platelets. Prostagl Leukotr Ess Fatty Acids 1993;49:587-595.

Srivastava R, Dikshit M, Srimal RC, Dhawan BN. Anti-thrombotic action of curcumin. Throm Res 1985;404:413-417.

Weiss RF. Herbal Medicine. Gothenhburg, Sweden; Beaconsfield, England: Beaconsfield Publishers, Ltd., 1988.

Yan LJ, Droy-Lefaix MT, Packer L. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Comm 1995;212:360-366.